Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV.

Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV.
复制标题

基于整合酶抑制剂的ART对未经艾滋病毒的艾滋病患者的NLRP3炎症体的影响。

DOI:
10.1093/ofid/ofaa459
复制
发表时间:
2020-10
影响因子:
4.2
通讯作者:
Zanni MV
Zanni MV
中科院分区:
医学3区
文献类型:
--
作者:
Toribio M;Burdo TH;Fulda ES;Cetlin M;Chu SM;Feldpausch MN;Robbins GK;Neilan TG;Melbourne K;Grinspoon SK;Zanni MV

文献摘要

参考文献

被引文献

相似文献

NOD样受体蛋白家族pyrin domain containing 3(NLRP 3)炎性体在HIV背景下被激活,有助于促动脉粥样硬化性炎症。在抗逆转录病毒治疗的HIV初治患者(与对照组相比)中,NLRP 3炎性小体的关键成分caspase-1的水平显著增加。6个月的埃替拉韦/可比司他/恩曲他滨/富马酸替诺福韦酯显著降低了与CD 4 +/CD 8+比值恢复相关的caspase-1水平。 临床试验注册。ClinicalTrials.gov NCT 01766726。 
The NOD-like receptor protein family pyrin domain containing 3 (NLRP3) inflammasome, activated in the setting of HIV, contributes to pro-atherogenic inflammation. Among antriretroviral therapy–naïve people with HIV (vs controls), levels of caspase-1—a key component of the NLRP3 inflammasome—were significantly increased. Six months of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate significantly decreased caspase-1 levels in association with CD4+/CD8+ ratio recovery. Trial registration. ClinicalTrials.gov NCT 01766726.
DOI: 10.1016/j.ahj.2018.12.016
发表时间: 2019-06-01
影响因子: 4.8
作者:
Grinspoon, Steven K.;Fitch, Kathleen V.;Douglas, Pamela S.
通讯作者: Douglas, Pamela S.
DOI: 10.1016/s2352-3018(15)00006-5
发表时间: 2015-03-01
期刊: LANCET HIV
影响因子: 16.1
作者:
Mussini, Cristina;Lorenzini, Patrizia;Monforte, Antonella d'Arminio
通讯作者: Monforte, Antonella d'Arminio
DOI: 10.1089/aid.2016.0234
发表时间: 2017-02-01
影响因子: 1.5
作者:
Cai, Rentian;Liu, Li;Lu, Hongzhou
通讯作者: Lu, Hongzhou
DOI: 10.1093/infdis/jiv004
发表时间: 2015-08-01
影响因子: 6.4
作者:
Hileman, Corrilynn O.;Kinley, Bruce;Mccomsey, Grace A.
通讯作者: Mccomsey, Grace A.
DOI: 10.1001/jamacardio.2016.0846
发表时间: 2016-07-01
期刊: JAMA CARDIOLOGY
影响因子: 24
作者:
Zanni, Markella V.;Toribio, Mabel;Grinspoon, Steven K.
通讯作者: Grinspoon, Steven K.